Co-Chairs
Massimiliano Gnecchi, MD, PhD, FESC, Professor, University of Pavia & IRCCS Policlinico, Italy
Miguel Forte, MD, PhD, President-Elect ISCT; CEO Kiji Tx; EiR AdBio, AdBio Partners, Belgium
Speakers
Nicola Elvassore, PhD, Professor, University of Padova, Italy
Khalid Shah, PhD, Professor, Harvard Medical School, USA
Andras Nagy, PhD, HonD, FRSC, Senior Investigator, Lunenfeld-Tanenbaum Research Institute, Canada
As the demand for advanced therapies continues to grow, improvements in CGT manufacturing workflow are becoming increasingly necessary. Despite recent advances, the translation of cell and gene therapies to the clinic is still hampered by obstacles that prevent these innovative technologies from becoming standards of care.
This session brings together eminent speakers that will provide insights into the road to the clinic and navigating it successfully to avoid pitfalls.
Professor
University of Pavia & Fondazione IRCCS Policlinico San Matteo
Chair